← Back to Treatments
🏅 FDA Orphan Designation

Zirgan

ganciclovir

Manufacturer: Sirion Therapeutics, Inc.

Indicated for:
Transient infantile hypertriglyceridemia and hepatosteatosisOrphanOBSOLETE: Herpes simplex virus keratitis

FDA-Approved Indications (2)

Treatment of acute herpetic keratitis (dendritic ulcers)

ZIRGAN is indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older.

Population: adults and pediatric patients aged 2 years and older

Indications & Usage

1 INDICATIONS AND USAGE ZIRGAN is indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older. ZIRGAN is a nucleoside analog antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older. ( 1 )

💙 Support Programs

View all →
Ganciclovir sodium
Roche
Apply ↗
ZIRGAN
Bausch Lomb
Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.